The Efficacy of a Plant Based Formulation in the Symptomatic Management of Mild COVID-19 Cases: A Double Blind, Randomized Controlled Trial

Authors

  • Sanjib kumar Das
  • Durga Prasad Dash
  • Pradip Kumar Panda
  • Sandhya Sadana
  • Reddy M Ravi Kumar
  • Venkatesh Hari K
  • Divya Kanchibhotla

Abstract

Background: The COVID-19 pandemic has infected millions of people globally. There is a need for integrated modern and traditional systems of medicine to work together to find effective solutions quickly.

Methods: NAOQ19 is a plant based formulation of 13 herbs. 50 COVID-19 patients were enrolled in the study. RT-PCR analysis was done on day 1, day 5 and day 10. Clinical symptoms were noted daily.

Result: NAOQ19 arm showed a higher population with RT-PCR negative compared to the placebo arm on Day 5 (76% vs 0%) On Day 5, NAOQ19 arm showed a complete recovery from few symptoms while by Day 10, they showed complete recovery from all symptoms, unlike the placebo arm which showed only 10.5% of the population with clinical recovery on day 10.

Conclusion: NAOQ19 facilitated a faster recovery from all clinical features of COVID-19, when compared to the placebo group. No side effects were observed during the entire study duration.

CTRI Registration: CTRI/2021/08/036025

Downloads

Published

2023-01-18

How to Cite

Das, S. kumar, Dash, D. P., Panda, P. K., Sadana, S., Kumar, R. M. R., K, V. H., & Kanchibhotla, D. (2023). The Efficacy of a Plant Based Formulation in the Symptomatic Management of Mild COVID-19 Cases: A Double Blind, Randomized Controlled Trial. Archives of Clinical and Medical Case Reports, 7(1), 5–12. Retrieved from https://fortunejournals.org/ojs/index.php/acmcr/article/view/22695